Ahmad, F., Mitchell, R., Houben, T., Palo, A., Yasdati, T., Parnell, A., Patel, K., Shiri-Sverdlov, R. and Leake, D. ORCID: https://orcid.org/0000-0002-1742-6134 (2021) Cysteamine decreases low density lipoprotein oxidation, causes regression of atherosclerosis and improves liver and muscle function in LDL receptor deficient mice. JAHA: Journal of the American Heart Association, 10 (18). ISSN 2047-9980 doi: https://doi.org/10.1161/JAHA.120.017524

Wen, Y., Ahmad, F., Mohri, Z., Weinberg, P. D. and Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134 (2019) Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice. Atherosclerosis, 291. pp. 9-18. ISSN 0021-9150 doi: https://doi.org/10.1016/j.atherosclerosis.2019.09.019

Ahmad, F. and Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134 (2019) Lysosomal oxidation of LDL alters lysosomal pH, induces senescence and increases secretion of pro-inflammatory cytokines in human macrophages. Journal of Lipid Research, 60. pp. 98-110. ISSN 1539-7262 doi: https://doi.org/10.1194/jlr.M088245

Palmer, C., Peri, F., Neumann, F., Ahmad, F., Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134 and Pirianov, G. (2018) The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling. Innate Immunity, 24 (7). pp. 411-421. ISSN 1753-4267 doi: https://doi.org/10.1177/1753425918798904

Ahmad, F. and Leake, D. ORCID: https://orcid.org/0000-0002-1742-6134 (2018) Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: a possible explanation as to why the clinical trials of antioxidants might have failed. Chemistry and Physics of Lipids, 213. pp. 13-24. ISSN 0009-3084 doi: https://doi.org/10.1016/j.chemphyslip.2018.03.001

Ahmad, F. (2017) Lysosomal oxidation of Low Density Lipoproteins. PhD thesis, University of Reading.